Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Congestive heart failure iron
Introduction
Overview
Overview
Iron
Iron
Indications for Iron
Background
European Society of Cardiology’s 2021 HF guidelines
European Society of Cardiology’s 2021 HF guidelines
The ECS states[1]:
- “It is recommended that all patients with HF be periodically screened for anaemia and iron deficiency with a full blood count, serum ferritin concentration, and TSAT.” a Class of recommendation: I “Is recommended or is indicated”; Level of evidence C “Consensus of opinion of the experts and/or small studies, retrospective studies, registries”
- “Intravenous iron supplementation with ferric carboxymaltose should be considered in symptomatic patients with LVEF <45% and iron deficiency, defined as serum ferritin <100 ng/mL or serum ferritin 100299 ng/mL with TSAT <20%, to alleviate HF symptoms, improve exercise capacity and QOL”
- “Intravenous iron supplementation with ferric carboxymaltose should be considered in symptomatic HF patients recently hospitalized for HF and with LVEF <50% and iron deficiency, defined as serum ferritin <100 ng/mL or serum ferritin 100299 ng/mL with TSAT <20%, to reduce the risk of HF hospitalization”
Trials
Trials
References
References
- ↑ McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M; et al. (2021). “2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure”. Eur Heart J. 42 (36): 3599–3726. doi:10.1093/eurheartj/ehab368. PMID 34447992 Check
|pmid=value (help).
Editor-In-Chief:
C. Michael Gibson, M.S., M.D. [1];